HomeCAPLIPOINT • NSE
add
Caplin Point Laboratories Ltd
Previous close
₹2,000.60
Day range
₹1,973.50 - ₹2,035.90
Year range
₹1,225.00 - ₹2,641.00
Market cap
152.34B INR
Avg Volume
118.12K
P/E ratio
29.68
Dividend yield
0.25%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 5.28B | 16.03% |
Operating expense | 1.50B | 50.00% |
Net income | 1.43B | 17.25% |
Net profit margin | 26.99 | 1.05% |
Earnings per share | — | — |
EBITDA | 1.93B | 34.02% |
Effective tax rate | 17.77% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.03B | 22.85% |
Total assets | 32.09B | 18.92% |
Total liabilities | 3.22B | -8.28% |
Total equity | 28.86B | — |
Shares outstanding | 76.04M | — |
Price to book | 5.48 | — |
Return on assets | — | — |
Return on capital | 16.16% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.43B | 17.25% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1990
Website
Employees
3,406
